| Drug Name |
Porfimer sodium |
| Drug ID |
BADD_D01803 |
| Description |
The purified component of hematoporphyrin derivative, it consists of a mixture of oligomeric porphyrins. It is used in photodynamic therapy (hematoporphyrin photoradiation); to treat malignant lesions with visible light and experimentally as an antiviral agent. It is the first drug to be approved in the use of photodynamic therapy in the United States. |
| Indications and Usage |
Indicated in the treatment of esophageal cancer. |
| Marketing Status |
approved; investigational |
| ATC Code |
L01XD01 |
| DrugBank ID |
DB00707
|
| KEGG ID |
D03327
|
| MeSH ID |
D017323
|
| PubChem ID |
135577896
|
| TTD Drug ID |
D02JDL
|
| NDC Product Code |
76128-155 |
| UNII |
Y3834SIK5F
|
| Synonyms |
Dihematoporphyrin Ether | Ether, Dihematoporphyrin | Dihematoporphyrin Ester | Porfimer | DHP Ether | Porfimer Sodium | Photofrin | Photofrin II |
